Work

Dapagliflozin: A Newly Approved SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Year: 2014

Type: article

Source: Pharmacy and Wellness Review

Authors: Ann Marie Ruhe, Rachel Muhlenkamp, Austin L. Brown, Emily Blum, Sandra L. Hrometz

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3100728353

FWCI:

Cites:

Cited by:

Related to: 20